An overview: OCT, Cataract surgery, Diplopia and SLT
Date: 26/03/2019
Venue: 16 Marion St, Leichhardt, NSW, 2040
Provider: Dr Nisha Sachdev
Contact: Nisha Sachdev, [E] nishasachdev002@gmail.com, [P] 0410 991 509
Learning Objectives
- Participants will be able to describe the optical principles of OCT
- Participants will be able to decide the reliability of OCT in difficult cases
- Participants will be able to describe the history of phacoemulsification
- Participants will be able to describe the current intraocular lenses
- Participants will be able to describe future intraocular lenses
- Participants will be able to describe potential issues with SLT
- Participants will be able to identify patients who will benefit from prisms for diplopia
- Participants will be able to prescribe prisms
Max points awarded: 5.25
Session Information
| Name |
|---|
| OCT : an outline |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 0.75 |
| Name |
|---|
| OCT: interpretation |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 0.75 |
| Name |
|---|
| Phaco: when did it begin |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 0.75 |
| Name |
|---|
| IOL's : current and new |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.50 |
| Name |
|---|
| SLT: issues |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 0.75 |
| Name |
|---|
| Diplopia: management |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 0.75 |
| Name | Activity Type | Therapeutic? | Manufacturer/ Supplier? | Points for attending & Passing Assessment |
|---|---|---|---|---|
| OCT : an outline | Face to Face with Assessment | No | No | 0.75 |
| OCT: interpretation | Face to Face with Assessment | No | No | 0.75 |
| Phaco: when did it begin | Face to Face with Assessment | No | No | 0.75 |
| IOL's : current and new | Face to Face with Assessment | No | No | 1.50 |
| SLT: issues | Face to Face with Assessment | No | No | 0.75 |
| Diplopia: management | Face to Face with Assessment | No | No | 0.75 |